Exabis Library
Welcome to the e-CCO Library!
P620: Pivoting in a pandemic: The impact of COVID-19 on the provision of care for patients with Inflammatory Bowel Disease – A retrospective study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P620: Stapled end-to-side vs. side-to-side anastomosis after ileocecectomy for Crohn’s disease: a propensity score-matched analysis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P621 Physician preferences for biologics (originator vs. biosimilar) for the treatment of ulcerative colitis in France, Germany and the UK
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P621: Combination treatment of biologics with immunomodulator increases risk of infection after discharge in biologics naive steroid refractory acute severe ulcerative colitis patient: A KASID multicenter study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P621: Efficacy and safety of golimumab in ulcerative colitis. Preliminary data from a multicenter Italian study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P621: Faecal calprotectin after the induction of anti-TNF therapy predicts mucosal healing in patients with ulcerative colitis: A prospective single-centre study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P621: Lactose intolerance assessed by analysis of genetic polymorphism, breath test and symptoms in patients with inflammatory bowel disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P621: Real-world effectiveness and safety of vedolizumab and anti-TNF in biologic-naive Crohn’s disease patients: results from the EVOLVE study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P621: Secure Electronic Document Signing Uptake in Biologic Prescribing for Immune Mediate Diseases
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P622 Recovery of nutrient deficiency as a predictor of remission in inflammatory bowel diseases
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P622: Change in Dietary Inflammatory Index Score in patients with Crohn's disease and healthy volunteers following the Groningen Anti Inflammatory Diet (GrAID)
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P622: Child outcome in IBD pregnancy: early vs. late discontinuation of IFX therapy
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P622: Comparison of long-term outcomes of infliximab and adalimumab in biologic-naïve patients with ulcerative colitis
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P622: Comparison of midterm outcomes in Pediatric Crohn’s Disease patients treated with either Exclusive Enteral Nutrition or Corticosteroids around disease diagnosis– a population based study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P622: Efficacy of probiotics in inflammatory bowel disease: systematic review and meta-analysis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P622: Surgery for severely active ulcerative colitis in the era of new medical treatment: The impacts of medications on surgery avoidance, and short-term and long-term surgical outcomes
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P623 Cumulative incidence of infliximab use after a first flare of acute severe colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P623: Colorectal cancer, colectomy rates and inflammatory bowel disease activity following liver transplantation in primary sclerosing cholangitis: a systematic review and meta-analysis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P623: Mucosal eosinophils as markers of post-induction vedolizumab response in paediatric Ulcerative Colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P623: Quality of life as predictor of biological levels decay in inflammatory bowel diseases
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM